Henan Lingrui Pharmaceutical Co., Ltd. (SHA:600285)
China · Delayed Price · Currency is CNY 21.06
-0.17 (-0.80%)
Oct 16, 2026, 3:00 PM CST
SHA:600285 Market Cap
SHA:600285 has a market cap or net worth of 11.94 billion as of October 16, 2026. It is the 7,142nd most valuable company in the world and the 1,349th biggest in China. Its market cap has decreased by 6.94% in one year.
Market Cap
11.94B
Enterprise Value
10.84B
Revenue
3.90B
Global Rank
Country Rank
#1,349 China
PE Ratio
15.32
ChartMarket Cap Chart
Since January 2, 2001, SHA:600285's market cap has increased from 2.12B to 11.94B, an increase of 463.75%. That is a compound annual growth rate of 6.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 11.94B | 2.40% |
| Dec 31, 2025 | 11.66B | -6.54% |
| Dec 31, 2024 | 12.48B | 29.34% |
| Dec 29, 2023 | 9.65B | 31.14% |
| Dec 30, 2022 | 7.36B | -17.51% |
| Dec 31, 2021 | 8.92B | 85.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nanjing King-Friend Biochemical Pharmaceutical | 13.16B |
| Zhejiang Hisun Pharmaceutical | 12.70B |
| Shenzhen Hepalink Pharmaceutical Group | 12.37B |
| Guobang Pharma | 12.23B |
| Beijing Aosaikang Pharmaceutical | 11.81B |
| Zhejiang Medicine | 11.49B |
| Tibet Rhodiola Pharmaceutical Holding Co. | 11.47B |
| Porton Pharma Solutions | 11.30B |